Kausik Ray
Professor of Public Health at Imperial College London
Schools
- Imperial College London
Links
Biography
Imperial College London
Kausik Ray is Professor of Public Health at the School of Public Health, the Director of the Imperial Centre for Cardiovascular Disease Prevention and the Deputy Director of the Imperial Clinical Trial Unit, Imperial College London and a Consultant Cardiologist.
Professor Ray received his medical education (MBChB) at the University of Birmingham, his MD at the University of Sheffield, a postdoctoral fellowship at Harvard Medical School and an MPhil in epidemiology from the University of Cambridge.
Professor Ray’s research interests focus on preventing the global consequences of atherosclerosis through large-scale population studies evaluating the burden of disease and improving risk prediction and through the study of novel therapies in the setting of multi-centre international clinical trials to offer solutions to help prevent death and disability from cardiovascular disease. As such, he is the global PI of several ongoing Cardiovascular trials and registries.
His publications are included in the NEJM, Lancet, JAMA, Circulation, JACC and EHJ amongst others and have received over 54,000 citations (2019 H index of 68, i10 of 159) and in 2018 he was listed by Clarivate Analytics as among the top 1% of authors cited globally in clinical medicine.
The impact of his novel research findings has contributed to current US and European guidelines amongst others.
An active member of the EAS, Professor Ray has contributed to more than 6 EAS Consensus Panel statements, been an invited speaker at the EAS annual congress for several years, was an EAS program committee member for 2015 (Glasgow) and 2017 (Prague) as well as his ongoing contributions to masterclasses and other EAS educational activities. Since 2017 he has served on the EAS Executive committee.
In 2014 he independently initiated and obtained funding for the EAS FH studies collaboration, the first global registry of its kind, now encompassing over 68 countries and approximately 60,000 cases, for which he is the lead.
Prof Ray has worked extensively to extend the EAS mission across Europe, the Asia Pacific, Gulf region and Latin America through education and collaborations.
Finally, Prof Ray firmly believes in the need to encourage and mentor young scientists to become part of the EAS and to contribute to the prevention of atherosclerosis globally.
Videos
Prof Kausik Ray gives an analysis of the PCSK9 inhibitor outcomes studies
AHA 2019 : Results Of The BETonMACE Trial — Prof Kausik K Ray
WHF Roadmap for Cholesterol | Prof Kausik Ray
Prof. Kausik Ray: Late Breaking Session at EAS Congress 2019
Read about executive education
Other experts
Popular Courses
Looking for an expert?
Contact us and we'll find the best option for you.